Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

791-highlights-from-the-inaugural-international-cancer-microbiome-consortium-meeting-icmc-5-6-september-2017-london-uk

Conference Report: Highlights from the Inaugural International Cancer Microbiome Consortium Meeting (ICMC), 5–6 September 2017, London, UK

Alasdair J Scott, Claire A Merrifield, James L Alexander, Julian R Marchesi, James M Kinross

20 Dec 2017

https://doi.org/10.3332/ecancer.2017.791

Abstract | Full Article | PDF

770-highlights-from-the-win-2017-symposium-26-27-june-2017-paris-france-expediting-global-innovation-in-precision-cancer-medicine

Conference Report: Highlights from the WIN 2017 Symposium, 26–27 June 2017, Paris, France: ‘Expediting Global Innovation in Precision Cancer Medicine’

Will Davies

27 Sep 2017

https://doi.org/10.3332/ecancer.2017.770

Abstract | Full Article | PDF

721-dual-role-of-inflammatory-mediators-in-cancer

Review: Dual role of inflammatory mediators in cancer

TG Shrihari

23 Feb 2017

https://doi.org/10.3332/ecancer.2017.721

Abstract | Full Article | PDF

703-biomarkers-come-of-age-pd1-in-the-frontline-and-cell-cycle-therapy-swells-the-ranks-of-personalised-therapy-in-the-european-society-of-medical-oncology-esmo-congress-copenhagen-7-10-october-2016

Conference Report: Biomarkers come of age: PD1 in the frontline and cell cycle therapy swells the ranks of personalised therapy in the European Society of Medical Oncology (ESMO) congress, Copenhagen, 7–10 October 2016

Will Davies

16 Dec 2016

https://doi.org/10.3332/ecancer.2016.703

Abstract | Full Article | PDF

691-cancer-immunotherapy-from-the-lab-to-clinical-applications-potential-impact-on-cancer-centres-organisation

Conference Report: Cancer Immunotherapy: from the lab to clinical applications. Potential impact on cancer centres’ organisation

Linda Cairns, Sandrine Aspeslagh, Andrea Anichini, Jon Amund Kyte, Christian Blank, Paolo Ascierto, Nicolle Rekers, Per Thor Straten, Ahmad Awada

9 Nov 2016

https://doi.org/10.3332/ecancer.2016.691

Abstract | Full Article | PDF

676-conditional-survival-of-metastatic-renal-cell-carcinoma-patients-treated-with-high-dose-interleukin-2

Clinical Study: Conditional survival of metastatic renal cell carcinoma patients treated with high-dose interleukin-2

David M Gill, David D Stenehjem, Kinjal Parikh, Joseph Merriman, Arun Sendilnathan, Archana M Agarwal, Andrew W Hahn, Sumati Gupta, Srinivas Kiran Tantravahi, Wolfram E Samlowski, Neeraj Agarwal

29 Sep 2016

https://doi.org/10.3332/ecancer.2016.676

Abstract | Full Article | PDF

669-highlights-from-the-2016-win-symposium-27-29-june-2016-paris-personalised-therapy-beyond-next-generation-sequencing

Conference Report: Highlights from the 2016 WIN Symposium, 27–29 June 2016, Paris: personalised therapy beyond next-generation sequencing

Richard Schilsky, Will Davies

24 Aug 2016

https://doi.org/10.3332/ecancer.2016.669

Abstract | Full Article | PDF

660-role-of-nanotechnology-and-gene-delivery-systems-in-trail-based-therapies

Review: Role of nanotechnology and gene delivery systems in TRAIL based therapies

George E Naoum, Fady Tawadros, Ammad Ahmad Farooqi, Muhammad Zahid Qureshi, Sobia Tabassum, Waleed Arafat, Donald J Buchsbaum

1 Aug 2016

https://doi.org/10.3332/ecancer.2016.660

Abstract | Full Article | PDF

649-cancer-associated-thrombotic-microangiopathy

Review: Cancer-associated thrombotic microangiopathy

K Govind Babu, Gita R Bhat

28 Jun 2016

https://doi.org/10.3332/ecancer.2016.649

Abstract | Full Article | PDF

646-squamous-cell-carcinoma-of-the-rectum-a-consequence-of-immunosuppression-resulting-from-inhibiting-tumour-necrosis-factor-tnf

Case Report: Squamous cell carcinoma of the rectum: a consequence of immunosuppression resulting from inhibiting tumour necrosis factor (TNF)?

Alexandra Silverton, Roy A Raad, Leah Katz, Andrea Downey, Franco M Muggia

7 Jun 2016

https://doi.org/10.3332/ecancer.2016.646

Abstract | Full Article | PDF

More from ecancer